Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Multiple Head and Neck Cancers: Molecular and Immunologic underpinnings

    July 12, 2025

    Clinical Staging, Histopathological Features and Treatment Outcomes in Malignant Melanoma: A 10-Year Retrospective Single-Center Study

    July 12, 2025

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»Corrected QT prolongation among chemotherapy – treated patients: A study of a Romanian center
    Volume 26, Issue 6

    Corrected QT prolongation among chemotherapy – treated patients: A study of a Romanian center

    November 30, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Cristina Crisan1, Calin Cainap1,3*, Anca Farcas3,4, Tiberiu Moldovan1, Eduard Radu1, Ovidiu Bochis1, Gabriela Morar-Bolba1, Adina Stan5*, Alina Bereanu6*, Catalin Vlad1,2, Patriciu Achimas1,2*, Simona Cainap2,3

    1“Prof. Dr. Ion Chiricuta” Oncology Institute of Cluj-Napoca, Romania.

    2Emergency County Hospital for Children, Pediatric Clinic no 2, Cluj-Napoca, Romania.

    3“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania.

    4Emergency County Hospital, Internal Medicine no 1, Cluj-Napoca, Romania.

    5Department of Neuroscience, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania.

    6Faculty of Medicine, “Lucian Blaga”University of Sibiu, Sibiu, Romania.

    *These authors contributed equally to this article.

    Summary

    Purpose: Chemotherapy cardiotoxicity sometimes occurs as QTc prolongation, which may lead to ventricular arrhythmia. We assessed incidence of QTc prolongation among chemotherapy-treated patients.

    Methods: We enrolled 396 consecutive patients receiving chemotherapy in the Oncology Institute of Cluj-Napoca, Romania. 870 ECGs were performed at baseline and every 2 months, for 5 assessments, during 2016.

    Results: Most patients were diagnosed with gastro-intestinal tumors and received regimens containing more than one drug. No particular chemotherapy regimen was proved to significantly increase QTc. Maximum QTc was recorded after 4 months, when we also found the maximum incidence of increased QTc (>470ms), of 3.73% and of increased ΔQTc (>60ms), of 4%. Female gender was associated with a higher baseline QTc=421 ms, ± 26.9 (p=0.02). Age was linked to higher QTc and is also an independent variable predicting QTc prolongation (for QTc>480ms, p=0.02), as well as increase of ΔQTc (p<0.001). The number of prior chemotherapy lines correlates with baseline QTc (p<0.0001), with QTc prolongation after 2 months (p=0.01) and predicts higher ΔQTc after 2 months (p=0.01), although within normal range. There was no additive effect during all the 5 assessments.

    Conclusion: Our results confirm QTc prolongation with chemotherapy and a special attention should be paid to previously treated patients and to elderly patients.

    Key words: chemotherapy, cardiotoxicity, QTc prolongation.

    Full Text: PDF

    Original Article
    Previous ArticleChemotherapy in cholangiocarcinoma – experience of a tertiary cancer center from Romania
    Next Article Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC) in the treatment of primary and metastatic pleural malignancies – is extension of indications possible?

    Related Articles

    Clinical Staging, Histopathological Features and Treatment Outcomes in Malignant Melanoma: A 10-Year Retrospective Single-Center Study

    Volume 28, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024
    Don't Miss
    Volume 28, 2025

    Multiple Head and Neck Cancers: Molecular and Immunologic underpinnings

    July 12, 2025

    Eleni Litsou1*, Anna Goussia2, Vasileios Ragos3, Georgios Katiniotis4 and George Zarkavelis5 Author informationCitations 1Department of…

    Clinical Staging, Histopathological Features and Treatment Outcomes in Malignant Melanoma: A 10-Year Retrospective Single-Center Study

    July 12, 2025

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.